ArticleCancers2020

Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients with Potential Benefit from FGFR Inhibitor Therapy.

Takehito Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.